Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Total return indices show comprehensive performance by including dividends. Understanding them helps investors assess risk and compare strategies effectively.
27,899 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
FactSet (FDS) investors are eyeing the Q3 2026 earnings with questions about growth, margins, and product strategy. T...
Berkshire Hathaway reduced its cash hoard to $373.3 billion by year-end 2025, a 2.1% drop from September, as Greg Abe...
Direxion has unveiled SKHL, a 2X leveraged ETF tied to SK hynix, signaling a new foray into the memory-chip space. Th...
A fresh Goldman Sachs memo warns that risk premia have fallen to crisis-era levels, signaling a potential stock marke...
Tariffs roiled markets, sending GLD down as real interest rates climbed and inflation stayed sticky. The gold ETF rem...
Analysts map a long-range path for SoFi Technologies, with a potential move into the upper 40s by 2030 as digital ban...
Stocks edge higher on renewed ceasefire hopes and a calmer oil market, lifting the Nasdaq Composite and broad market ...
Vail Resorts is signaling a strategic pivot away from the iconic $1,000 Epic Pass as season results lag and weather c...
SoundHound AI is pursuing an enterprise voice AI niche built on data ownership and brand protection. This article bre...
Broadcom is riding a powerful AI wave, with revenue in key AI-adjacent areas jumping. Yet the stock moved lower after...
A major payer shift could unlock stronger demand for Eli Lilly’s obesity and GLP-1 products. This in-depth analysis e...